Poređenje nekih funkcionalnih i antropometrijskih parametara kao faktora rizika za fragilnost među polovima kod starih osoba

Natalija Hadživuković; Jelena Pavlović; Maja Račić; Nedeljka Ivković; Olivera Kalajdžić; Ranka Perućica; Srdjan Živanović; Ljubiša  Kucurski

doi:10.5937/opmed28-35467

Natalija Hadživuković Department of Health Care, University of East Sarajevo, Faculty of Medicine Foca, The Republic of Srpska, Bosnia and Herzegovina https://orcid.org/0000-0002-2425-3171
dr Jelena Pavlović Department of Health Care, University of East Sarajevo, Faculty of Medicine Foca, The Republic of Srpska, Bosnia and Herzegovina https://orcid.org/0000-0002-8591-4316
dr Maja Račić Department of Primary Health Care and Public Health, School of Medicine, University of Sarajevo, https://orcid.org/0000-0001-6165-9130
dr Nedeljka Ivković Department of Oral Rehabilitation, School of Medicine, University of East Sarajevo; Bosnia and Herzegovina https://orcid.org/0000-0002-7890-4144
dr Olivera Kalajdžić Department of Psychology, Faculty of Medicine in Foca, University of East Sarajevo https://orcid.org/0000-0002-2946-0559
dr Ranka Perućica Department of Pedagogy, Faculty of Medicine in Foca, University of East Sarajevo https://orcid.org/0000-0002-2946-0559
dr Srdjan Živanović Department of Health Care, University of East Sarajevo, Faculty of Medicine Foca, The Republic of Srpska, Bosnia and Herzegovina
dr Ljubiša Kucurski Department of Nursing, The Public Institution Medical College, Prijedor

DOI: https://doi.org/10.5937/opmed28-35467

Ključne reči: Stare osobe, fragilnost, funkcionalni status, antropometrijski parametri

Sažetak

Uvod. Specifična karakteristika starijih osoba je njihova
krhost /ili fragilnost. Zbog rasprostranjenosti, fragilnost je
potrebno shvatiti kao prioritet javnog zdravlja.
Cilj rada. Ispitati povezanost funkcionalnih i antropometrijskih
parametara sa fragilnošću kod osoba starosti preko
65 godina.
Metod. Istraživanje je dizajnirano kao studija preseka
i obuhvatilo je 446 starijih lica. Kao instrumenti istraživanja
korišćeni su opšti upitnik, za procjenu funkcionalnog statusa
Tinetti test i od antropometrijskih parametara obim nadlaktice
i obim srednje cirkumferencije potkoljenice. Od statističkih
testova koristili smo χ2 test, a Pirsonova (Pearson) korelacijska
analiza korišćena je za analizu korelacije.
Rezultati. Osobe ženskog pola su imale lošiji funkcionalni
status, hod i ravnotežu u odnosu na osobe muškog pola
(χ2=4,125; p<0,127). Uočeno je da su ispitanici muškog pola
imali veće vrijednosti obima nadlaktice (26,96± 3,44) u odnosu
na ženski pol, dok su osobe ženskog pola imale veće vrijednosti
obima srednje cirkumferencije potkoljenice (32,66±
6,29).Analizirajući povezanost antropometrijskih mjerenja sa
ukupnim skorom Tinetti testa i u odnosu na pol ispitanika,
uočeno je da između parametara.postoji korelaciona analiza
Zaključak. Visok procenat ispitanika starijih od 65 godina
ima loš funkcionalni status, kao i niže vrijednosti antropometrijskih
markera, što ukazuje na to da oni mogu biti
potencijalni faktori rizika za nastanak fragilnosti kod osoba
strarijeg životnog doba.

Reference

Karunananthan S, Wolfson C, Bergman H,

Beland F, Hogan DB. A multidisciplinary

systematic literature review on frailty:

overview of the methodology used by the

Canadian Initiative on Frailty and Aging.

BMC Med Res Methodol 2009;9:68.

Lepeleire JD, IIiffe S, Mann E, IIiffe S,

Mann E, Degryse JM, et al. Frailty: an

emerging concept for general practice. Br

J Gen Pract 2009;59: 177-187.

Rodríguez-Mañas L, Féart C, Mann

G, Viña J, Chatterji S, Chodzko-Zajko

WJ et al. Searching for an operational

definition of frailty: a delphi method based

consensus statement. The frailty operative

definition-consensus conference project.

J Gerontol A Biol Sci Med Sci 2013;68:

-7.

Fedarko NS. The Biology of Aging and

Frailty. Clin Geriatr Med

;27:27–37.

Clegg A; Young J; Iliffe S; Rikkert MO;

Rockwood K. Frailty in elderly people.

Lancet. 2013; 381:752-762.

Xue QL Frailty Syndrome; Definition

and Natural History. Clin Geriatr

Med2011;27:1–15.

Buckinx F, Rolland Y, Reginster JY,

Ricour C, Petermans J, Bruyère O. Burden

of frailty in the elderly population:

perspectives for a public health challenge.

Arch Public Health 2015;73:19.

Gale CR, Cooper C, Sayer AA. Prevalence

of frailty and disability: findings from the

English Longitudinal Study of Ageing.Age

Ageing 2015;44:162–165.

Carneiro JA, Ramos GCF, Barbosa ATF,

Mendonça JMG, Costa FM, Caldeira

AP. Prevalence and factors associated

with frailty in non-institutionalized older

adults. Rev Bras Enferm 2016;69:435-42.

Collard RM, Boter H, Schoevers RA,

Oude Voshaar RC. Prevalence of frailty

in community-dwelling older persons:

a systematic review. J Am Geriatr Soc

;60:1487–1492.

Tinetti ME, Williams TF, Mayewski R.

Fall Risk Index for elderly patients based

onnumber of chronic disabilities. Am J

Med 1986:80:429-434.

Physical status: the use and interpretation

of anthropometry. WHO Expert

Committee Report. World Health Organ

Tech Rep Ser 1995;854:1-452.

Rolland Y, Abellan van Kan G, Gillette-

Guyonnet S, Vellas B. Cachexia versus

sarcopenia. Curr Opin Clin Nutr Metab

Care 2011;14:15–21.

Peterson SJ, Mozer M. Differentiating

sarcopenia and cachexia among patients

with cancer. Nutr Clin Pract 2017;32:

–9.

Saliba D, Elliott M, Rubenstein LZ,

Solomon DH, Young RT, Kamberg CJ, et

al. The Vulnerable Elders Survey: a tool

for identifying vulnerable older people

in the community. J Am Geriatr Soc

;49:1691–9.

Zhang XS, Liu YH, Zhang Y, Xu Q, Yu

Q, Yu Xet al. Handgrip strength as a

predictor of nutritional status in Chinese

elderly inpatients at hospital admission.

Biomed Environ Sci 2017;30:802-10.

Argilés JM, Busquets S, Stemmler

B, López-Soriano FJ. Cachexia and

sarcopenia: mechanisms and potential

targets for intervention. Curr Opin

Pharmacol 2015;22:100–6.

Zdzieblik D, Oesser S, Baumstark

MW, Gollhofer A, König D. Collagen

peptide supplementation in combination

with resistance training improves body

composition and increases muscle strength

in elderly sarcopenic men: a randomised

controlled trial. Br J Nutr 2015;114:

–45.

Chen LK, Liu LK, Woo J, Assantchia

P, Auyeung TW, Bahyah KS, et al.

Sarcopenia in Asia: consensus report of

the Asian Working Group for Sarcopenia. J

Am Med Dir Assoc 2014;15:95-101.

Lee D, Shook RP, Drenowatz C, Blair

SN. Physical activity and sarcopenic

obesity: definition, assessment,

prevalence, and mechanism. Future Sci

OA2016;2:FSO127.

Polyzos SA, Margioris AN. Sarcopenic

obesity. Hormones (Athens, Greece)

;17:321-331.

JafariNasabian P, Inglis JE, Wendimere R,

Kelly OJ, Ilich JZ. Aging human body:

changes in bone, muscle, and body fat with

consequent changes in nutrient intake.J

Endocrinol 2017;234:R37–R51.

Kalinkovich A, Livshits G. Sarcopenic

obesity or obese sarcopenia: a cross talk

between age-associated adipose tissue and

skeletal muscle inflammation as a main

mechanism of the pathogenesis. Ageing

Res Rev2017;35:200–221.

Wannamethee SG, Atkins JL. Muscle

loss and obesity: the health implications of

sarcopenia and sarcopenic obesity. Proc

Nutr Soc2015;74:405–12.

Kwon HJ, Ha YC, Park HM.

The Reference Value of Skeletal

Muscle Mass Index for Defining the

Sarcopenia of Women in Korea. J Bone

Metab2015;22:71-5.